More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$42.55B
EPS
13.59
P/E ratio
41.2
Price to sales
10.03
Dividend yield
--
Beta
1.548939
Previous close
$545
Today's open
$542.17
Day's range
$534.36 - $547.61
52 week range
$518.55 - $769.98
show more
CEO
Jonathan J. Mazelsky
Employees
11000
Headquarters
Westbrook, ME
Exchange
Nasdaq Global Select
Shares outstanding
78882997
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending
Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging technologies, among other things. Utilities companies must navigate significant changes when hyperscalers enter their territory—in some cases, a new data center operator may immediately become one of the largest customers in the region.
MarketBeat • Jul 14, 2026

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
Zacks Investment Research • Jul 14, 2026

ALC vs. IDXX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Jul 7, 2026

IDEXX Laboratories to Release 2026 Second Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX websi.
Business Wire • Jul 1, 2026

Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Jun 30, 2026

Is the Options Market Predicting a Spike in IDEXX Laboratories Stock?
Investors need to pay close attention to IDXX stock based on the movements in the options market lately.
Zacks Investment Research • Jun 29, 2026

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Jun 11, 2026

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Jun 9, 2026

Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Jun 4, 2026

Baron Asset Fund Q1 2026 Contributors, Detractors And Recent Activity
SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. CoStar Group's shares fell due to multiple compression driven by rising fears about the potential impact of AI on the company's business.
Seeking Alpha • Jun 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell IDEXX Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.